Table 2

Major longitudinal clinical features at baseline and exacerbations of all samples

Longitudinal featuresAll samples (n=716)VisitsP value*
Baseline (n=446)Exacerbations (n=270)
FEV11.4 (0.5)1.5 (0.5)1.2 (0.5)<0.001
FVC2.8 (0.9)3.0 (0.8)2.5 (0.9)<0.001
FEV1/FVC ratio0.5 (0.2)0.5 (0.2)0.5 (0.2)0.26
CAT score21.1 (7.4)19.6 (7.1)24.2 (7.0)<0.001
C reactive protein‡5.0 (11.0)3.0 (5.0)10.0 (27.0)<0.001§
Blood neutrophil count (×109 cells/L)5.5 (2.3)4.9 (1.7)6.2 (2.7)<0.001
Blood lymphocyte count (×109 cells/L)1.8 (0.7)1.8 (0.6)1.8 (0.7)0.49
Blood monocyte count (×109 cells/L)0.7 (0.3)0.6 (0.2)0.7 (0.3)<0.001
Blood eosinophil count (×109 cells/L)‡0.2 (0.2)0.2 (0.2)0.2 (0.2)0.18§
Blood basophil count (×109 cells/L)0.0 (0.0)0.1 (0.0)0.0 (0.0)0.01
Sputum neutrophil count % ‡78.8 (33.8)75.1 (34.0)84.2 (28.5)<0.001§
Sputum lymphocyte count %‡0.0 (0.5)0.0 (0.3)0.2 (1.0)0.028§
Sputum eosinophil count %‡0.8 (2.0)0.8 (2.2)0.5 (2.0)0.07§
Sputum macrophage count %‡13.0 (21.2)14.5 (23.2)8.5 (19.0)<0.001§
Sputum epithelial count %‡3.2 (8.0)4.0 (9.8)2.0 (4.8)<0.001§
  • *P value was calculated for baseline and exacerbations comparison using t-test unless stated below.

  • †Data present as mean (SD) unless stated below.

  • ‡Median (IQR).

  • §Mann-Whitney-Wilcoxon Test.

  • FEV1, forced expiratory volume in one second; FVC, forced vital capacity.